Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus

Diabetologia

Volumn 54, Issue 9, 2011, Pages 2247-2253

  Suzuki, S ^a   Koga, M ^b   Amamiya, S ^c   Nakao, A ^d   Wada, K ^e   Okuhara, K ^f   Hayano, S ^g   Sarhat, A R ^a   Takahashi, H ^a   Matsuo, K ^a   Tanahashi, Y ^a   Fujieda, K ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^c Sapporo Tokushukai Hospital   (Japan)

^d JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^e NARA MEDICAL UNIVERSITY   (Japan)

^f Tenshi Hospital   (Japan)

^g ANJO KOSEI HOSPITAL   (Japan)

Author keywords

Fetal haemoglobin; Glycated albumin; HbA1c; Neonatal diabetes

Indexed keywords

GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; HEMOGLOBIN F; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED SERUM ALBUMIN; HEMOGLOBIN; INSULIN; SERUM ALBUMIN;

AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INFANT; INSULIN TREATMENT; MALE; NEONATAL DIABETES MELLITUS; NEWBORN DISEASE; PREPRANDIAL PLASMA GLUCOSE; PRIORITY JOURNAL; SELF MONITORING; COMPARATIVE STUDY; METABOLISM; NEWBORN; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; HUMANS; INFANT; INFANT, NEWBORN; INSULIN; MALE; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 80054714989     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2211-8     Document Type: Article

References (31)

1. Aguilar-Bryan L, Bryan J (2008) Neonatal diabetes mellitus. Endocr Rev 29:265-291 (Pubitemid 351679699)
2. Temple IK, Gardner RJ, Mackay DJ et al (2000) Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes 49:1359-1366 (Pubitemid 30624238)
3. Suzuki S, Makita Y, Mukai T et al (2007) Molecular basis of neonatal diabetes in Japanese patients. J Clin Endocrinol Metab 92:3979-3985 (Pubitemid 47607650)
4. Gloyn AL, Pearson ER, Antcliff JF et al (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838-1849 (Pubitemid 38917250)
5. Cohen MP (1998) Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy? J Diabet Complications 2:214-217
6. Koenig RJ, Peterson CM, Jones RL et al (1976) Correlation of glucose regulation and haemoglobin AIc in diabetes mellitus. N Engl J Med 295:417-420
7. Jeffcoate SL (2004) Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med 1:657-665 (Pubitemid 38916208)
8. Bry L, Chen PC, Sacks DB (2001) Effects of haemoglobin variants and chemically modified derivatives on assays for glycohaemoglobin. Clin Chem 47:153-163 (Pubitemid 32142912)
9. Felner EI, McGrath M (2008) Inaccurate haemoglobin A1C levels in patients with type 1 diabetes and hereditary persistence of haemoglobin F. J Pediatr 153:137-139
10. Rohlfing CL, Connolly SM, England JD et al (2008) The effect of elevated fetal haemoglobin on haemoglobin A1c results: five common haemoglobin A1c methods compared with the IFCC reference method. Am J Clin Pathol 129:811-814
11. Ohls RK, Christensen RD (2008) Developmental of the hematopietic system. In: Kliegman RM, Beheman RE, Jenson HB, Santon BF (eds) Nelson textbook of pediatrics, 18th edn. Saunders Elsevier, Philadelphia, pp 1997-2003
12. Chapelle JP, Teixeira J, Maisin D et al (2010) Multicentre evaluation of the Tosoh HbA1c G8 analyser. Clin Chem Lab Med 48:365-371
13. Koga M, Kasayama S (2010) Clinical impact of glycated albumin as another glycemic control marker. Endocr J 57:751-762
14. Tahara Y, Shima K (1995) Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18:440-447
15. 1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 54:139-144 (Pubitemid 46481682)
16. Koga M, Hashimoto K, Murai J et al (2011) Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia. Clin Chim Acta 412:253-257
17. Koga M, Murai J, Saito H et al. (2011) Measurement of glycated haemoglobin and glycated albumin in umbilical cord: evaluation of the glycemic control indicators in neonates. J Perinatol 6:430-433
18. Nishida H, Sakamoto S, Sakanoue M (1985) New fetal growth curves for Japanese. Acta Paediatr Scand Suppl 319:62-67 (Pubitemid 16118021)
19. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus (2010) Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Diabetes Invest 1:212-228
20. Kouzuma T, Usami T, Yamakoshi M et al (2002) An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta 324:61-71 (Pubitemid 35245496)
21. Armbruster DA (1987) Fructosamine: structure, analysis, and clinical usefulness. Clin Chem 33:2153-2163
22. Yamanouchi T, Akanuma Y (1994) Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control. Diabetes Res Clin Pract 24(Suppl):S261-S268
23. Yoshioka S (1983) A new metabolic parameter, 1-deoxyglucose (1,5-anhydroglucitol), for diabetes mellitus. Shohnika 24:405-410 (in Japanese)
24. Senecal PE, Douville P, Simard S et al (1988) The relationship between serum fructosamine and albumin. Clin Chim Acta 173:239-241
25. Abe F, Yano M, Minami Yet al (1989) Alterations in fructosamine and glycated albumin levels during childhood. Ann Clin Biochem 26:328-331 (Pubitemid 19185701)
26. Buckley RH (2008) T lymphocytes, B lymphocytes, and natural killer cells. In: Kliegman RM, Beheman RE, Jenson HB, Santon BF (eds) Nelson textbook of pediatrics, 18th edn. Saunders Elsevier, Philadelphia, pp 873-879
27. Danze P, Tarjoman A, Rousseaux J et al (1987) Evidence for an increased glycation of IgG in diabetic patients. Clin Chim Acta 166:143-153 (Pubitemid 17100854)
28. Shima K, Ito N, Abe F et al (1988) High-performance liquid chromatographic assay of serum glycated albumin. Diabetologia 31:627-631
29. Hanafusa T, Imagawa A (2007) Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab 3:36-45 (Pubitemid 46006611)
30. Imagawa A, Hanafusa T, Uchigata Y et al (2003) Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 26:2345-2352 (Pubitemid 36993324)
31. Koga M, Murai J, Saito H et al (2010) Serum glycated albumin to haemoglobin A1C ratio can distinguish fulminant type 1 diabetes mellitus from type 2 diabetes mellitus. Ann Clin Biochem 47:313-317